Abbott Laboratories (ABT) EBITDA (2008 - 2026)
Abbott Laboratories (ABT) EBITDA from Jun 30, 2008 to Mar 31, 2026. The TTM Abbott Laboratories (ABT) EBITDA is $9.18B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Abbott Laboratories (ABT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +8.37% |
| 3 Years TTM | +3.78% |
| 5 Years TTM | +2.64% |
| 10 Years TTM | +9.70% |
| All Time TTM | +4.31% |
Annual EBITDA change of Abbott Laboratories (ABT)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $1.73B | -81.81% |
| 2025 | $9.49B | +16.19% |
| 2024 | $8.16B | +5.29% |
| 2023 | $7.75B | -19.35% |
| 2022 | $9.62B | -3.03% |
| 2021 | $9.92B | +51.34% |
| 2020 | $6.55B | +16.79% |
| 2019 | $5.61B | +18.11% |
| 2018 | $4.75B | +81.99% |
| 2017 | $2.61B | -31.84% |
| 2016 | $3.83B | +2.43% |
| 2015 | $3.74B | +6.28% |
| 2014 | $3.52B | +14.90% |
| 2013 | $3.06B | +12.41% |
| 2012 | $2.72B | -9.95% |
| 2011 | $3.02B | -58.55% |
| 2010 | $7.30B | -2.04% |
| 2009 | $7.45B | +10.39% |
| 2008 | $6.75B | +19.36% |
| 2007 | $5.65B | N/A |
Comparison Abbott Laboratories (ABT) five years EBITDA CAGR with competitors
Abbott Laboratories (ABT) five years EBITDA CAGR is 2.64%.